These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9833947)
21. Islet amyloid polypeptide in the islets of Langerhans: friend or foe? Gebre-Medhin S; Olofsson C; Mulder H Diabetologia; 2000 Jun; 43(6):687-95. PubMed ID: 10907112 [TBL] [Abstract][Full Text] [Related]
22. Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus. Höppener JW; Jacobs HM; Wierup N; Sotthewes G; Sprong M; de Vos P; Berger R; Sundler F; Ahrén B Exp Diabetes Res; 2008; 2008():697035. PubMed ID: 18497871 [TBL] [Abstract][Full Text] [Related]
23. Increased plasma levels of islet amyloid polypeptide in patients with primary hyperparathyroidism. Valdermarsson S; Leckström A; Westermark P; Bergenfelz A Eur J Endocrinol; 1996 Mar; 134(3):320-5. PubMed ID: 8616529 [TBL] [Abstract][Full Text] [Related]
24. Lack of effect of islet amyloid polypeptide in causing insulin resistance in conscious dogs during euglycemic clamp studies. Kassir AA; Upadhyay AK; Lim TJ; Moossa AR; Olefsky JM Diabetes; 1991 Aug; 40(8):998-1004. PubMed ID: 1860564 [TBL] [Abstract][Full Text] [Related]
25. The effect of different glucose endovenous administrations on amylin and insulin blood concentration in healthy subjects. Testa I; Ceneralli S; Testa R; Bonfigli AR; Recchioni A; Paoletti P; De Sio G Boll Soc Ital Biol Sper; 1996; 72(3-4):103-8. PubMed ID: 8771910 [TBL] [Abstract][Full Text] [Related]
30. Biologically active human islet amyloid polypeptide/amylin in transgenic mice. van Hulst KL; Born W; Muff R; Oosterwijk C; Blankenstein MA; Lips CJ; Fischer JA; Höppener JW Eur J Endocrinol; 1997 Jan; 136(1):107-13. PubMed ID: 9037136 [TBL] [Abstract][Full Text] [Related]
31. Integrated mathematical model to assess beta-cell activity during the oral glucose test. Thomaseth K; Kautzky-Willer A; Ludvik B; Prager R; Pacini G Am J Physiol; 1996 Mar; 270(3 Pt 1):E522-31. PubMed ID: 8638701 [TBL] [Abstract][Full Text] [Related]
32. Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. Höppener JW; Verbeek JS; de Koning EJ; Oosterwijk C; van Hulst KL; Visser-Vernooy HJ; Hofhuis FM; van Gaalen S; Berends MJ; Hackeng WH Diabetologia; 1993 Dec; 36(12):1258-65. PubMed ID: 8307253 [TBL] [Abstract][Full Text] [Related]
33. Amyloid-induced β-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment. Montane J; de Pablo S; Castaño C; Rodríguez-Comas J; Cadavez L; Obach M; Visa M; Alcarraz-Vizán G; Sanchez-Martinez M; Nonell-Canals A; Parrizas M; Servitja JM; Novials A FASEB J; 2017 Dec; 31(12):5296-5306. PubMed ID: 28821639 [TBL] [Abstract][Full Text] [Related]
34. Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunction. Couce M; Kane LA; O'Brien TD; Charlesworth J; Soeller W; McNeish J; Kreutter D; Roche P; Butler PC Diabetes; 1996 Aug; 45(8):1094-101. PubMed ID: 8690157 [TBL] [Abstract][Full Text] [Related]
35. Role of islet amyloid polypeptide secretion in insulin-resistant humans. Kautzky-Willer A; Thomaseth K; Pacini G; Clodi M; Ludvik B; Streli C; Waldhäusl W; Prager R Diabetologia; 1994 Feb; 37(2):188-94. PubMed ID: 8163054 [TBL] [Abstract][Full Text] [Related]
36. Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion. Ludvik B; Clodi M; Kautzky-Willer A; Schuller M; Graf H; Hartter E; Pacini G; Prager R J Clin Invest; 1994 Nov; 94(5):2045-50. PubMed ID: 7962550 [TBL] [Abstract][Full Text] [Related]
37. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation. Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779 [TBL] [Abstract][Full Text] [Related]
38. Identification of the amyloid-degrading enzyme neprilysin in mouse islets and potential role in islet amyloidogenesis. Zraika S; Hull RL; Udayasankar J; Clark A; Utzschneider KM; Tong J; Gerchman F; Kahn SE Diabetes; 2007 Feb; 56(2):304-10. PubMed ID: 17259373 [TBL] [Abstract][Full Text] [Related]
39. Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro. Verchere CB; D'Alessio DA; Palmiter RD; Kahn SE Diabetologia; 1994 Jul; 37(7):725-8. PubMed ID: 7958546 [TBL] [Abstract][Full Text] [Related]
40. Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Eriksson J; Nakazato M; Miyazato M; Shiomi K; Matsukura S; Groop L Diabetologia; 1992 Mar; 35(3):291-3. PubMed ID: 1563587 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]